BEIRNE WEALTH CONSULTING SERVICES, LLC Lineage Cell Therapeutics, Inc. Transaction History

BEIRNE WEALTH CONSULTING SERVICES, LLC portfolio value:

$51,000
portfolio value

BEIRNE WEALTH CONSULTING SERVICES, LLC quarter portfolio value change:

-28.48%
quarter

Lineage Cell Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -20K $1.13 45K
Q2 2022 share 0.00% 0 shares 1K $1.58 45K
Q1 2022 share 0.00% 0 shares -40K $1.54 45K
Q4 2021 share 0.00% 0 shares -3K $2.5 45K
Q3 2021 share 0.00% 0 shares -15K $2.52 45K
Q2 2021 share 0.00% 0 shares 22K $2.85 45K
Q1 2021 share 0.00% 0 shares 27K $2.35 45K
Q4 2020 share 0.00% 0 shares 37K $1.76 45K
Q3 2020 share Decrease -35.71% -25K shares -19K $0.94 45K
Q2 2020 share Increase +55.56% 25K shares 24K $0.87 70K
Q1 2020 share 0.00% 0 shares -3K $0.83 45K
Q4 2019 share 0.00% 0 shares -4K $0.89 45K
Q3 2019 share Increase 0.00% 45K shares 44K $0.98 45K